Predictors of Understaging with EUS and PET-CECT in Early Esophageal Carcinoma
Journal of Gastrointestinal Cancer · 2025
DOI: 10.1007/s12029-024-01147-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastrointestinal Cancer, 2025. Verfasst von Karthik Venkataramani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Tata Memorial Hospital & Homi Bhabha National Institute, Dr. E. Borges Road, Parel, Mumbai, 400012, India. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Neoplasm Staging, Endosonography, Positron Emission Tomography Computed Tomography. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tata Memorial Hospital - TMC.
Abstract (Originalsprache)
Background
The clinicoradiological staging for esophageal cancer is fraught with variable accuracy, potentially depriving patients who have been understaged of the benefit of neoadjuvant therapy, which has been shown to improve long-term survival in locally advanced malignancies. It is imperative to identify these high-risk tumors for tailored treatment.
Methods
Retrospective analysis of a prospective database of patients undergoing esophagectomy for carcinoma esophagus between 2011 and 2019. Patients with clinicoradiological early-stage esophageal carcinoma (T1/2 and N0), staged with EUS and fluoro-deoxy-glucose positron emission tomography with contrast-enhanced computed tomography (FDG PET-CECT), and undergoing upfront surgery were included. Demographic profile, staging, perioperative outcomes, and follow-up data were extracted from electronic records and analyzed using SPSS 26.0.
Results
During this period, we performed 1496 esophagectomies, of which 68 patients (4.5%) underwent upfront surgery for early-stage tumors. The overall concordance between clinical and surgical staging was 55.8%. The positive predictive value (PPV) of EUS for T1, T2, and N0 was 81.6%, 46.7%, and 82.4%, respectively, with 10.2% and 17% upstaging to T3 and N + , respectively. On multivariate analysis, T2 on EUS and tumors longer than 3.5 cm and having standardized uptake value (SUVmax) > 3.05 on FDG PET were strong predictors of stage migration. The 3-year overall survival (OS) of the entire cohort was 74.2%, while those who were understaged had a worse outcome, with a 3-year survival of 48.2%.
Conclusion
Endoscopic T2 stage, length more than 3.5 cm, and SUVmax more than 3.05 are associated with significant understaging and hence should be considered for neoadjuvant therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Oncology, Tata Memorial Hospital & Homi Bhabha National Institute, Dr. E. Borges Road, Parel, Mumbai, 400012, India.
- Department of Surgical Oncology, Tata Memorial Hospital & Homi Bhabha National Institute, Dr. E. Borges Road, Parel, Mumbai, 400012, India. sabitajiwnani@gmail.com.
- Director of Thoracic Surgery, Max Nanavati Super Speciality Hospital, Mumbai, India.
Förderung
- Tata Memorial Hospital - TMC
Zitieren
APA
Venkataramani, K., Jiwnani, S., Niyogi, D., Tiwari, V., Pramesh, C. S., & Karimundackal, G. (2025). Predictors of Understaging with EUS and PET-CECT in Early Esophageal Carcinoma. Journal of Gastrointestinal Cancer. https://doi.org/10.1007/s12029-024-01147-y
Vancouver
Venkataramani K, Jiwnani S, Niyogi D, Tiwari V, Pramesh CS, Karimundackal G. Predictors of Understaging with EUS and PET-CECT in Early Esophageal Carcinoma. Journal of Gastrointestinal Cancer. 2025. doi:10.1007/s12029-024-01147-y
BibTeX
@article{Venkataramani2025,
author = {Venkataramani, Karthik and Jiwnani, Sabita and Niyogi, Devayani and Tiwari, Virendrakumar and Pramesh, C S and Karimundackal, George},
title = {Predictors of Understaging with EUS and PET-CECT in Early Esophageal Carcinoma},
journal = {Journal of Gastrointestinal Cancer},
year = {2025},
doi = {10.1007/s12029-024-01147-y}
}
EUVIMED